Acetaminophen API Market Outlook (2023 to 2033)

The global acetaminophen API market is anticipated to surpass US$ 1,180.4 million in 2023. With the drug coming in very handy as a palliative in pain relief and in combination with other drugs in a plethora of medical conditions, the drug is available over the counter (OTC) in the form of extended-release tablets exuding analgesic effects, the overall demand for acetaminophen market is projected to exhibit a CAGR of 3.4% between 2023 and 2033 totaling US$ 1,648.2 million by 2033.

Attributes Details
Acetaminophen API Market Share (2022) US$ 137.2 million
Acetaminophen API Market Share (2023) US$ 1,180.4 million
Acetaminophen API Market Share (2033) US$ 1,648.2 million
Acetaminophen API Market Share (2023 to 2033) 3.4%

Acetaminophen API, commonly known as Paracetamol or Tylenol, is a drug that is used as a first line of defense in any painful condition. This miracle drug displays antipyretic and analgesics effect when associated with various other drugs. Acetaminophen is found in over-the-counter (OTC) as with plenty of drugs which include pain relievers and sleep anxiety pills.

Discovered in 1877, the drug is typically used for mild to moderate pain. It is generally prescribed either individually or in association with cold medication. The name 'Paracetamol' is approved by the International Non-proprietary, Britain and Australia, while Acetaminophen is the name which is approved and used in the United States and Japan. Tylenol is an appropriate analgesic choice for people suffering from hypertension.

The usage of acetaminophen grade is higher due to its wide utilization in the drug development process. While it is widely used in the pharmaceutical industry as a pain killer, it offers a lucrative opportunity for the growth of the Acetaminophen API market in the forecasted period. Aside from this, the acetaminophen drug is combined with various drugs and is available in various forms, but it is mostly available in the form of extended-release tablets for showing analgesic effects. These drugs are administered to patients who are habituated to ingesting salicylates and those suffering from hypersensitive propensities, including bronchial asthmatics. It comes under the NSAIDs (nonsteroidal anti-inflammatory drugs) category because of its capacity to repress the cyclooxygenase (COX) pathways.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Acetaminophen API Market Historical Analysis (2018 to 2022) Vs. Forecast Outlook (2023 to 2033)

According to Future Market Insights, demand for acetaminophen API experienced sales incline at a CAGR of 2.1% from 2018 to 2022. Increasing awareness regarding palliative care in critically ill patients is boosting the adoption of analgesics for pain management. Since the prevalence of pain is over 75% in advanced disease conditions, sales of the drug are expected to gain traction in the forthcoming years.

Acetaminophen usage is higher due to its wide utilization in the drug development process. While it is widely used in the pharmaceutical industry as a pain killer, it offers a lucrative opportunity for the growth of the Acetaminophen API market in the forecast period. Besides, acetaminophen is combined with various drugs and is available in various forms, but it is mostly available in the form of extended-release tablets for showing analgesic effects. But heavy usage of this drug can cause serious adverse effects & can build toxicity, leading to other diseases.

At the same time, limitations on the export of key drug candidates may hamper future expansion prospects. For instance, the Indian government has put limitations on the export of 27 active pharmaceutical ingredients (APIs) and completed portions of drugs made with those APIs since the outbreak of COVID-19. Johnson and Johnson's (New Brunswick, NJ, United States) Tylenol (acetaminophen/paracetamol) is among the medications whose supply chains were impacted.

The request may influence worldwide pharmaceutical supply chains. India is a crucial area of pharmaceutical manufacturing for the drug market in different countries. The nation houses drug manufacturing units possessed by contract fabricating associations (CMOs) and others claimed by local and global biopharma organizations for in-house manufacturing.

Which Drivers Underpin Acetaminophen API Industry Expansion?

Rising cases of chronic diseases to rope in significant growth

Rising cases of chronic diseases and conditions that require pain management solutions regularly are vital in improving market growth. Additionally, also increasing need for medicines for pain relief, rising health awareness among consumers, rising applications of acetaminophen in the dye industry and chemical industry, and rising recommendations of acetaminophen by doctors for mild pain and fever are the key factors among others, driving the acetaminophen (Paracetamol) market. But heavy usage of this drug can cause serious adverse effects & can build toxicity, leading to other diseases.

According to CDC (Center for Disease Control), in 2019, 20.2% of adults had chronic pain, and 7.1% had chronic pain that discouraged work activities. Similarly, in the United Kingdom, around 22% of patients with diabetes were found to have peripheral neuropathic pain. Paracetamol can be combined with other pain management drugs sold through prescription only, which is expected to continue boosting sales.

Furthermore, rising technological advancements and modernization in the production of paracetamol, rising research and development activities in the healthcare sector, and rising emerging markets with an increasing geriatric population base may further open up opportunities for the acetaminophen (Paracetamol) market in the forecasted period of 2021 to 2028. Tylenol does not interfere with high BP medications as other drugs do.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors Are Limiting the Growth of the Market?

Increasing access to OTC drugs has a telling impact on the acetaminophen market.

The increasing availability of generic medicines amid intense competition coupled with the growing popularity of sustainable chemistry are the key factors, among others, that may obstruct the market growth and may further challenge the growth of the acetaminophen (Paracetamol) market in the forecast period mentioned above.

Acetaminophen toxicity may lead to acute liver failure, although various risk factors raise the probability of acute liver damage, such as alcohol, and the intake of such substances, increases the risk of liver failure after consuming acetaminophen.

Category-wise Insights

By Product Type, which Acetaminophen API Category May Remain Prominent?

IV administered Acetaminophen to remain prominent in managing pain

Intravenous (IV) acetaminophen is increasingly used worldwide for pain control for various indications. There is no accurate analysis regarding intravenous administration being more suitable over oral acetaminophen medication. The category ushers in amplified growth.

Acetaminophen injection is used together with other medicines (e.g., narcotic pain relievers) to relieve moderate to severe pain.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Region-wise Insights

North America Continues Dominance in the Global Acetaminophen API Market

Heart ailments not unheeded with acetaminophen administration

North America accounted for 33.4% of the global revenue share in the acetaminophen API market as of 2022, with the United States being the leading contributor. The research concludes that over 90 million American adults have at least one type of cardiovascular disease. Hence, when recommending an analgesic, it's important to consider patients' heart risks.

The combination of certain pain relievers with some medicinal therapies can interfere with cardiovascular treatment. Because of its safety and analgesic efficacy, the American Heart Association has identified acetaminophen as a first-line pain relief option for patients with or at high risk for cardiovascular disease.

North America is the second-leading region in terms of growth in the acetaminophen (Paracetamol) market due to rising healthcare spending and the availability of affordable drugs in this region. Rapid development and advancements, along with the changing topography, are going to offer a lucrative opportunity for the growth of the acetaminophen API market in North America during the forecasted period. Acetaminophen is also widely used and prescribed in North America.

How Growth May Unfold in the European Acetaminophen API Market?

Pain management to reaffirm growth in the European region

Europe is the region under the scanner in terms of growth in the acetaminophen (Paracetamol) market due to the rising need to manage pain and growing awareness in this region. In Germany, ibuprofen, naproxen, and paracetamol are widely available OTC at offline and internet pharmacies. Europe captured 26.2% of global market shares in 2022.

The wide availability of the drugs leads to intentional or unintentional overdose that affects the body and its functioning. Acute liver failure is a severe form of acute liver injury that can progress to multiple organs and causes failure. The overall incidence of acute liver failure in developed countries on a yearly basis was found to be 1 to 6 per million people.

In Germany, almost 200 to 500 cases of acute liver failure occur annually, affecting women more than men, accounting for 52% to 63% of cases. Furthermore, Germany invests significantly in healthcare research and infrastructure among all the nations that are a part of the European Union. According to the Federal Statistical Office, health expenditure in Germany accounted for US$ 440. 09 billion in 2019, which was one of the highest healthcare expenditures for healthcare among the relative EU member states. This signifies a pivotal market for acetaminophen.

The Start-Up Ecosystem: How Key Players Are Opening Frontiers for Future Growth?

  • In April 2022, Genexa Launched the First Ever Clean Acetaminophen Pain Relief Products for Adults. Genexa's Acetaminophen Extra Strength and Acetaminophen PM caplets have the same active ingredients and dosages of current category leaders but without artificial dyes, synthetic fillers, and other artificial preservatives.
  • In August 2021, Marksans Pharma received the United States FDA approval for Acetaminophen ER Tablets. This product approval endorses the ability of Marksans to develop and deliver products on a high-barrier platform technology of extended-release tablets.
  • In August 2022, KemPharm discovered and developed proprietary NME prodrugs that improve one or more of the attributes of approved drugs using its Ligand Activated Therapy (LAT). Lead product KP201/APAP is a product of hydrocodone formulated in combination with acetaminophen.

Key Market players

BOC Sciences, Tianjin Bofa Acetaminophen, Mallinckrodt Plc., Kemcolour International, Changshu Huagang Acetaminophen, Haohua Industry, Kangle Acetaminophen, Angene International Limited, and Anhui BBCA Acetaminophen are some prominent acetaminophen API manufacturers. With so many players present in the industrial growth of the acetaminophen market, the market remains highly competitive.

Recent Developments Observed by FMI:

  • In May 2022, Genexa introduced the first-ever clean adult acetaminophen pain relief products. Although Genexas Acetaminophen Extra Strength and Acetaminophen PM caplets lack artificial colors, synthetic fillers, and other artificial preservatives, they have the same active ingredients and doses as the current category leaders.
  • A campaign by WhiteGrey helped Haleon, a global consumer healthcare company, introduce its first organically derived pain relief medication to the market in April 2023. Launching with the marketing concept ‘Who Said Natural Hasn't Got What It Takes?,’ PanaNatra is the first product in a new ‘naturals’ subcategory from the makers of Panadol.

Key Players in the Global Market:

  • BOC Sciences
  • Tianjin Bofa Acetaminophen
  • Mallinckrodt plc
  • Kemcolour International
  • Chnagshu Huagang Acetaminophen
  • Haohua Industry
  • Kangle Acetaminophen
  • Angene International Limited
  • Anhui BBCA Acetaminophen
  • Granules India
  • Hebei Jihgeng Acetaminophen

Scope of the Report

Attributes Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ million for Value
Key Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa (MEA)
Key Countries Covered
  • United States
  • Canada
  • Germany
  • United Kingdom
  • Nordic
  • Russia
  • BENELUX
  • Poland
  • France
  • Spain
  • Italy
  • Czech Republic
  • Hungary
  • Rest of EMEAI
  • Brazil
  • Peru
  • Argentina
  • Mexico
  • South Africa
  • Northern Africa
  • GCC Countries
  • China
  • Japan
  • South Korea
  • India
  • ASEAN
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand
  • Others
Key Segments Covered
  • Type
  • End User
  • Product Form
  • Region
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Trend Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Acetaminophen API Market Segmentation

By Type:

  • Veterinary Drug Grade Acetaminophen API
  • Acetaminophen Grade Acetaminophen API

By End User:

  • Pharmaceutical Industry
  • Research Labs
  • Educational Institutes
  • Others

By Product Form:

  • Acetaminophen Tablets (Film-coated, Extended-release)
  • Oral Acetaminophen
  • Acetaminophen Suppository
  • Acetaminophen Injection
  • Others

By Indications:

  • Antipyretic Acetaminophen APIs
  • Acetaminophen Analgesics

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa (MEA)

Frequently Asked Questions

How Big is the Acetaminophen API Market?

The acetaminophen API market is slated to attain US$ 1,180.4 million in 2023.

What is the Market Demand of the Acetaminophen API?

The market demand of acetaminophen API is 3.4% CAGR through 2033.

Which Product Type is More Prominent in the Market?

IV administered acetaminophen is a prominent product type in the market.

Which Region Holds Monopoly in the Acetaminophen API Market?

North America holds market monopoly in the acetaminophen API market.

Who are the Manufacturers of Acetaminophen API?

Tianjin Bofa Acetaminophen, Mallinckrodt plc, and Kemcolour International are key manufacturers.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Tons) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Type, 2023 to 2033

        5.3.1. Veterinary Drug Grade

        5.3.2. Acetaminophen Grade

    5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Pharmaceuticals Industry

        6.3.2. Research Labs

        6.3.3. Educational institutes

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Form

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Product Form, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Product Form, 2023 to 2033

        7.3.1. Acetaminophen Tablets

        7.3.2. Oral Acetaminophen Solution

        7.3.3. Acetaminophen Suppository

        7.3.4. Acetaminophen Injection

        7.3.5. Others

    7.4. Y-o-Y Growth Trend Analysis By Product Form, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Product Form, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indications

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Indications, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Indications, 2023 to 2033

        8.3.1. Antipyretic Acetaminophen APIs

        8.3.2. Acetaminophen Analgesics

    8.4. Y-o-Y Growth Trend Analysis By Indications, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By Indications, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. South Asia and Pacific

        9.3.6. East Asia

        9.3.7. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. U.S.

            10.2.1.2. Canada

        10.2.2. By Type

        10.2.3. By End User

        10.2.4. By Product Form

        10.2.5. By Indications

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By End User

        10.3.4. By Product Form

        10.3.5. By Indications

    10.4. Key Takeaways

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Type

        11.2.3. By End User

        11.2.4. By Product Form

        11.2.5. By Indications

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By End User

        11.3.4. By Product Form

        11.3.5. By Indications

    11.4. Key Takeaways

12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. U.K.

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Western Europe

        12.2.2. By Type

        12.2.3. By End User

        12.2.4. By Product Form

        12.2.5. By Indications

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By End User

        12.3.4. By Product Form

        12.3.5. By Indications

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Poland

            13.2.1.2. Russia

            13.2.1.3. Czech Republic

            13.2.1.4. Romania

            13.2.1.5. Rest of Eastern Europe

        13.2.2. By Type

        13.2.3. By End User

        13.2.4. By Product Form

        13.2.5. By Indications

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type

        13.3.3. By End User

        13.3.4. By Product Form

        13.3.5. By Indications

    13.4. Key Takeaways

14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Bangladesh

            14.2.1.3. Australia

            14.2.1.4. New Zealand

            14.2.1.5. Rest of South Asia and Pacific

        14.2.2. By Type

        14.2.3. By End User

        14.2.4. By Product Form

        14.2.5. By Indications

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type

        14.3.3. By End User

        14.3.4. By Product Form

        14.3.5. By Indications

    14.4. Key Takeaways

15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. China

            15.2.1.2. Japan

            15.2.1.3. South Korea

        15.2.2. By Type

        15.2.3. By End User

        15.2.4. By Product Form

        15.2.5. By Indications

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Type

        15.3.3. By End User

        15.3.4. By Product Form

        15.3.5. By Indications

    15.4. Key Takeaways

16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Type

        16.2.3. By End User

        16.2.4. By Product Form

        16.2.5. By Indications

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Type

        16.3.3. By End User

        16.3.4. By Product Form

        16.3.5. By Indications

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. U.S.

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Type

            17.1.2.2. By End User

            17.1.2.3. By Product Form

            17.1.2.4. By Indications

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Type

            17.2.2.2. By End User

            17.2.2.3. By Product Form

            17.2.2.4. By Indications

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Type

            17.3.2.2. By End User

            17.3.2.3. By Product Form

            17.3.2.4. By Indications

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Type

            17.4.2.2. By End User

            17.4.2.3. By Product Form

            17.4.2.4. By Indications

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Type

            17.5.2.2. By End User

            17.5.2.3. By Product Form

            17.5.2.4. By Indications

    17.6. U.K.

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Type

            17.6.2.2. By End User

            17.6.2.3. By Product Form

            17.6.2.4. By Indications

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Type

            17.7.2.2. By End User

            17.7.2.3. By Product Form

            17.7.2.4. By Indications

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Type

            17.8.2.2. By End User

            17.8.2.3. By Product Form

            17.8.2.4. By Indications

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Type

            17.9.2.2. By End User

            17.9.2.3. By Product Form

            17.9.2.4. By Indications

    17.10. Poland

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Type

            17.10.2.2. By End User

            17.10.2.3. By Product Form

            17.10.2.4. By Indications

    17.11. Russia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Type

            17.11.2.2. By End User

            17.11.2.3. By Product Form

            17.11.2.4. By Indications

    17.12. Czech Republic

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Type

            17.12.2.2. By End User

            17.12.2.3. By Product Form

            17.12.2.4. By Indications

    17.13. Romania

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Type

            17.13.2.2. By End User

            17.13.2.3. By Product Form

            17.13.2.4. By Indications

    17.14. India

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Type

            17.14.2.2. By End User

            17.14.2.3. By Product Form

            17.14.2.4. By Indications

    17.15. Bangladesh

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Type

            17.15.2.2. By End User

            17.15.2.3. By Product Form

            17.15.2.4. By Indications

    17.16. Australia

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Type

            17.16.2.2. By End User

            17.16.2.3. By Product Form

            17.16.2.4. By Indications

    17.17. New Zealand

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Type

            17.17.2.2. By End User

            17.17.2.3. By Product Form

            17.17.2.4. By Indications

    17.18. China

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Type

            17.18.2.2. By End User

            17.18.2.3. By Product Form

            17.18.2.4. By Indications

    17.19. Japan

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Type

            17.19.2.2. By End User

            17.19.2.3. By Product Form

            17.19.2.4. By Indications

    17.20. South Korea

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Type

            17.20.2.2. By End User

            17.20.2.3. By Product Form

            17.20.2.4. By Indications

    17.21. GCC Countries

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Type

            17.21.2.2. By End User

            17.21.2.3. By Product Form

            17.21.2.4. By Indications

    17.22. South Africa

        17.22.1. Pricing Analysis

        17.22.2. Market Share Analysis, 2022

            17.22.2.1. By Type

            17.22.2.2. By End User

            17.22.2.3. By Product Form

            17.22.2.4. By Indications

    17.23. Israel

        17.23.1. Pricing Analysis

        17.23.2. Market Share Analysis, 2022

            17.23.2.1. By Type

            17.23.2.2. By End User

            17.23.2.3. By Product Form

            17.23.2.4. By Indications

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Type

        18.3.3. By End User

        18.3.4. By Product Form

        18.3.5. By Indications

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. BOC Sciences 

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

                19.1.1.5.2. Product Strategy

                19.1.1.5.3. Channel Strategy

        19.1.2. Tianjin Bofa Acetaminophen

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

                19.1.2.5.2. Product Strategy

                19.1.2.5.3. Channel Strategy

        19.1.3. Mallinckrodt plc

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

                19.1.3.5.2. Product Strategy

                19.1.3.5.3. Channel Strategy

        19.1.4. Kemcolour International

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

                19.1.4.5.2. Product Strategy

                19.1.4.5.3. Channel Strategy

        19.1.5. Changshu Huagang Acetaminophen

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

                19.1.5.5.2. Product Strategy

                19.1.5.5.3. Channel Strategy

        19.1.6. Haohua Industry

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

                19.1.6.5.2. Product Strategy

                19.1.6.5.3. Channel Strategy

        19.1.7. Kangle Acetaminophen

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

                19.1.7.5.2. Product Strategy

                19.1.7.5.3. Channel Strategy

        19.1.8. Angene International Limited

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

                19.1.8.5.2. Product Strategy

                19.1.8.5.3. Channel Strategy

        19.1.9. Anhui BBCA Acetaminophen

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

                19.1.9.5.2. Product Strategy

                19.1.9.5.3. Channel Strategy

        19.1.10. Granules India

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

                19.1.10.5.2. Product Strategy

                19.1.10.5.3. Channel Strategy

        19.1.11. Hebei Jihgeng Acetaminophin

            19.1.11.1. Overview

            19.1.11.2. Product Portfolio

            19.1.11.3. Profitability by Market Segments

            19.1.11.4. Sales Footprint

            19.1.11.5. Strategy Overview

                19.1.11.5.1. Marketing Strategy

                19.1.11.5.2. Product Strategy

                19.1.11.5.3. Channel Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Advanced Cancer Pain Management Market

February 2023

REP-GB-16622

299 pages

Healthcare

Acetaminophen Market

February 2022

REP-GB-14325

January 2023

332 pages

Explore Healthcare Insights

View Reports